Belite Bio (BLTE) Non-cash Items (2020 - 2025)

Belite Bio's quarterly Non-cash Items came in at $1.7 million in Q4 2025, down 99.38% year-on-year from $273.4 million in Q4 2024, and down 99.38% quarter-over-quarter from $273.4 million in Q4 2024.

Belite Bio has reported Non-cash Items for 6 years, with the latest figure at $1.7 million in Q4 2025.

  • For the quarter ending Q4 2025, Non-cash Items fell 99.38% year-over-year to $1.7 million; the trailing twelve-month figure through Dec 2025 stood at $1.7 million (down 99.38% YoY), and the FY2025 full-year result was $1.7 million, down 99.38% from the prior year.
  • Non-cash Items for Q4 2025 stood at $1.7 million, down from $273.4 million in the prior quarter.
  • The five-year high for Non-cash Items was $273.4 million in Q4 2024, with the low at $1.7 million in Q4 2025.
  • Average Non-cash Items over 5 years is $64.2 million, with a median of $10.5 million recorded in 2022.
  • Year-over-year, Non-cash Items soared 778.71% in 2024 and sank 99.38% in 2025.
  • Tracing BLTE's Non-cash Items over 5 years: stood at $4.5 million in 2021, then surged by 133.77% to $10.5 million in 2022, then surged by 197.04% to $31.1 million in 2023, then jumped by 778.71% to $273.4 million in 2024, then slumped by 99.38% to $1.7 million in 2025.
  • The last three Non-cash Items figures came in at $1.7 million (Q4 2025), $273.4 million (Q4 2024), and $31.1 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Belite Bio 4.92 Bn 4.45 Bn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 2.29 Mn
Dec 31, 2025 2.29 Mn
Dec 31, 2024 273.36 Mn
Dec 31, 2024 273.36 Mn
Dec 31, 2023 31.11 Mn
Dec 31, 2023 31.11 Mn
Dec 31, 2022 10.47 Mn
Dec 31, 2022 10.47 Mn
Dec 31, 2021 4.48 Mn
Dec 31, 2021 4.48 Mn
Dec 31, 2020 7.83 Mn
Dec 31, 2020 7.83 Mn